Stock listing

NB3 Stock Price, News, Filings & Events — Neurocrine Biosciences, Inc.

Selected listing: NB3 · GETTEX · EUR · DE

NB3:GETTEX is the listing for Neurocrine Biosciences, Inc. in Germany. The company specializes in developing and commercializing therapies for neurological and endocrine disorders, aiming to enhance patient outcomes. With a significant market capitalization of around €17.18 billion, Neurocrine is actively engaged in advancing innovative treatments to meet unmet medical needs. Recent news and filings reflect its ongoing commitment to research and development in this critical healthcare sector.

NB3:GETTEXEURDEUpdated July 24, 2026
Neurocrine Biosciences, Inc. logo
Ticker
NB3:GETTEX
Asset type
Stock
Market cap
$17.67B
Sector
Health Technology
Industry
Biotechnology
Exchange
GETTEX
Currency
EUR

Neurocrine Biosciences, Inc. NB3:GETTEX stock context

NB3:GETTEX is the listing for Neurocrine Biosciences, Inc. in Germany. The company specializes in developing and commercializing therapies for neurological and endocrine disorders, aiming to enhance patient outcomes. With a significant market capitalization of around €17.18 billion, Neurocrine is actively engaged in advancing innovative treatments to meet unmet medical needs. Recent news and filings reflect its ongoing commitment to research and development in this critical healthcare sector.

Research Neurocrine Biosciences, Inc.

Alternate listings